Literature DB >> 3943156

Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation.

C R Benedict, B Mathew, K A Rex, J Cartwright, L A Sordahl.   

Abstract

The role of platelets in contributing to occlusive coronary artery thrombus formation remains unresolved. A large number of studies have utilized in vitro techniques to study platelet aggregation. This report describes a model of spontaneous in vivo thrombus formation which involves application of current in the left circumflex coronary artery of the dog. Changes in mean coronary blood flow velocity (50% above control) are used to predict the point at which current can be discontinued without interrupting the ongoing process of thrombus formation. Thrombus formation proceeds to total vessel occlusion within 62 +/- 18 minutes after discontinuation of current. Coronary sinus plasma serotonin concentrations are used as an in vivo index of platelet aggregation during thrombus formation. Plasma serotonin levels increased only slightly above baseline levels during initial thrombus formation. Coronary sinus serotonin levels rose markedly after cessation of current, reaching a peak just prior to total vessel occlusion. The marked increase in serotonin concentration observed in the latter stages of thrombus formation strongly suggests that platelet aggregation is a significant factor in the evolution of an occlusive coronary thrombus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943156     DOI: 10.1161/01.res.58.1.58

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  15 in total

1.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

2.  Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17).

Authors:  D Duerschmied; M Canault; D Lievens; A Brill; S M Cifuni; M Bader; D D Wagner
Journal:  J Thromb Haemost       Date:  2009-05-08       Impact factor: 5.824

3.  Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

4.  Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats.

Authors:  L W Fu; J C Longhurst
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

5.  Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.

Authors:  P R Belcher; A J Drake-Holland; J W Hynd; M I Noble
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

6.  Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.

Authors:  M Prosdocimi; A Zatta; M Finesso
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

7.  Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.

Authors:  C R Benedict; J Ryan; B Wolitzky; R Ramos; M Gerlach; P Tijburg; D Stern
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Effect of encainide, ODE, MODE, and flecainide on ADP/5-HT induced platelet aggregation and in the anesthetized dog coronary artery stenosis-occlusion model of intravascular thrombosis.

Authors:  J S Fleming; J O Buchanan; F D Yocca; L G Iben; M J Antonaccio
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

9.  Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptors.

Authors:  B Manéglier; G J Guillemin; P Clayette; C Rogez-Kreuz; B J Brew; D Dormont; C Advenier; P Therond; O Spreux-Varoquaux
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

Review 10.  Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia.

Authors:  C M Spencer; R N Brogden
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.